Download Disini
World

Pfizer to supply US with additional 100M vaccines doses

[ad_1]

Pfizer and BioNTech will supply the U.S. with an additional 100 million doses of the COVID-19 vaccine under a new agreement

WASHINGTON — Pfizer and BioNTech will supply the U.S. with an additional 100 million doses of the COVID-19 vaccine under a new agreement.

The drugmakers said Wednesday that they expect to deliver all the doses by July 31.

Pfizer already has a contract to supply the government with 100 million doses of its vaccine, which requires two doses per patient.

Under the nearly $2 billion deal announced Wednesday, the companies will deliver at least 70 million of the additional doses by June 30, with the remaining 30 million doses to be delivered no later than July 31. The government also has the option to acquire up to an additional 400 million doses.

Health and Human Services Secretary Alex Azar said in a statement that the latest deal can give people confidence “that we will have enough supply to vaccinate every American who wants it by June 2021.”

Pfizer’s vaccine was the first to gain approval from the Food and Drug Administration and initial shipments went to states last week. It has now been joined by a vaccine from Moderna, which was developed in closer cooperation with scientists from the National Institutes of Health.

Moderna’s vaccine, which also requires two doses, comes under the umbrella of the government’s own effort, which is called Operation Warp Speed. That public-private endeavor was designed to have millions of vaccine doses ready and available to ship once a shot received FDA approval.

A law dating back to the Korean War gives the government authority to direct private companies to produce critical goods in times of national emergency. Called the Defense Production Act, it’s expected to be invoked to help Pfizer secure some raw materials needed for its vaccine.

Pfizer already had a contract to supply the government with 100 million doses of its vaccine under Operation Warp Speed, but government officials have said it’s more of an arms-length relationship with the company and they don’t have as much visibility into its operations.

Azar said last week that the government was negotiating with Pfizer for more doses, but details provided Tuesday about the company’s desire for better access to supplies are new.

The vaccine from Pfizer and German pharmaceutical BioNTech immediately raised hopes of taming a pandemic that has killed nearly 320,000 people in the U.S. and hobbled much of the national economy. Health care workers and nursing home residents topped the list as local TV stations across the country began broadcasting scenes of the first vaccinations. Some polls show skepticism about getting vaccinated may be easing.

The New York Times first reported the new details of negotiations between Pfizer and the Trump administration.

[ad_2]
Source link

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Download Disini